125 results
8-K
EX-1.1
dncvstarsebx0gbhuw
2 Apr 24
Entry into a Material Definitive Agreement
5:10pm
424B5
omvnd6x29tcqpq6
2 Apr 24
Prospectus supplement for primary offering
4:58pm
8-K
EX-99.1
2po7uofkrr4o
25 Mar 24
Sutro Biopharma Reports Full Year 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:30pm
8-K
EX-99.1
aqhqg1dxmnuz1ku2d
21 Nov 23
Departure of Directors or Certain Officers
4:05pm
UPLOAD
s9j mewiomfsfu3c6
16 Nov 23
Letter from SEC
12:00am